Feb 04, 2021 / 11:30AM GMT
Prateek Mandhana - Nomura Securities Co. Ltd., Research Division - Associate
Good evening, all. On behalf of Nomura Securities, we would like to welcome all to Thyrocare Technologies Limited 3Q FY '21 Earnings Call. Today, from the Thyrocare management team, we have with us Dr. A. Velumani, Chairman and Managing Director; Mr. Arindam Haldar, CEO; Mr. A. Sundararaju, CFO and Executive Director; Mr. Ramjee Dorai, Company Secretary; Mr. Sachin Salvi, Vice President, Finance; and Dr. Caesar Sengupta, Vice President, Operations.
So now without any further delay, I would like to hand over the call to Mr. Sachin Salvi, to give an update on the financials for Thyrocare. Over to you, Mr. Salvi.
Sachin Salvi -
Thank you, Prateek, and good evening. Thank you, everyone, for joining our post-results conference call for quarter ended 31st December 2020. I'll briefly update you about the key highlights of quarter 3 financial performance.
First, I'll start with revenue from operations. Our revenue from operations for the current quarter on a stand-alone basis have
Q3 2021 Thyrocare Technologies Ltd Earnings Call Transcript
Feb 04, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers